Los Angeles, CA, United States of America

John Joseph Mastrototaro

This inventor holds 84 USPTO granted patents and 13 published patent applications, plus 8 CIPO patents and 23 EPO patents, primarily in Closed-Loop Infusion Systems (CPC class A61M5-1723). Top assignees: Medtronic Minimed, Inc., Minimed, Inc., Eli Lilly and Company. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Joseph Mastrototaro. Retrieved from https://idiyas.com/inventor/john-joseph-mastrototaro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 84 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 3.7

ph-index = 50

Forward Citations = 42,282(Granted Patents)

Forward Citations (Not Self Cited) = 40,496(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Indianapolis, IN (US) (1993 - 1995)
  • Brentwood, CA (US) (1995)
  • Los Angeles, CA (US) (1995 - 2024)

Company Filing History:


Years Active: 1993-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Closed-Loop Control
Insulin Infusion
Glucose Sensor Calibration
Medical Device Communication
Automatic Adjustments
User-Configurable Systems
Safeguarding Techniques
Algorithm Estimator
Blood Glucose Measurements
Therapy Calibration
Sensor Redundancy
Physiological Sensors
84 patents (USPTO):Explore Patents

Title: John Joseph Mastrototaro: Innovator in Glucose Sensor Calibration and Infusion Systems

Introduction:

In the realm of medical technology and healthcare, the name John Joseph Mastrototaro stands tall. With a base in Los Angeles, CA (US), Mastrototaro has emerged as a prominent inventor, holding an impressive portfolio of 81 patents primarily in the field of medical devices. This article delves into Mastrototaro's latest patents, career highlights, notable collaborations, and his remarkable contributions to the industry.

Latest Patents:

Mastrototaro continues to make breakthroughs in medical technology, particularly in the areas of glucose sensor calibration and infusion systems. One of his notable inventions is the "System and/or method for glucose sensor calibration." This patent provides an innovative approach to calibrating sensor data and estimating blood glucose concentration, leading to more accurate glucose monitoring for individuals with diabetes.

Additionally, Mastrototaro holds another valuable patent titled "User-configurable closed-loop notifications and infusion systems incorporating the same." This invention focuses on facilitating the safe and effective delivery of fluids to patients by personalizing user notifications and integrating them into infusion devices. By tailoring alert configurations to individual needs, Mastrototaro aims to enhance user experience and optimize therapy outcomes.

Career Highlights:

Mastrototaro's career has been closely associated with renowned medical device companies. He has played a pivotal role in shaping the field of healthcare technology during his tenure with organizations like Medtronic Minimed, Inc. and Minimed, Inc. (now known as Medtronic Diabetes).

While working with Medtronic Minimed and Minimed Inc., Mastrototaro made significant contributions to the development and commercialization of advanced diabetes management technologies. His expertise has greatly influenced the way individuals manage their diabetes today, placing greater emphasis on accuracy, convenience, and personalized care.

Collaborations:

Throughout his career, Mastrototaro has had the privilege of collaborating with notable colleagues and experts in the field. Two individuals who have worked closely with Mastrototaro are Desmond Barry Keenan and William P. Van Antwerp. Their collective efforts have fostered a collaborative environment that has spurred innovation and fueled advancements in medical device technology.

Conclusion:

John Joseph Mastrototaro's contributions to the medical technology industry, particularly in the areas of glucose sensor calibration and infusion systems, have immensely benefited patients and healthcare professionals alike. With a stellar portfolio of 81 patents, his dedication and expertise have revolutionized the way diabetes is managed.

As an inventor, Mastrototaro's vision for personalized and accurate healthcare has shaped the development of innovative devices and systems. Through his collaboration with renowned organizations like Medtronic Minimed, Inc., and talented colleagues such as Desmond Barry Keenan and William P. Van Antwerp, Mastrototaro's work continues to make a lasting impact on the lives of individuals worldwide.

Disclaimer: The information presented in this article is based on publicly available data and may not encompass the entirety of John Joseph Mastrototaro's career and collaborations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…